Limits...
Predictability of the individual clinical outcome of extracorporeal shock wave therapy for cellulite.

Schlaudraff KU, Kiessling MC, Császár NB, Schmitz C - Clin Cosmet Investig Dermatol (2014)

Bottom Line: Impulses were homogeneously distributed over the posterior thigh and buttock area (resulting in 7,500 impulses per area).No statistically significant (ie, P<0.05) correlation was found between individual values for δ-1 and δ-2 and cellulite grade at baseline, BMI, weight, height, or age.The individual clinical outcome cannot be predicted by the patient's individual cellulite grade at baseline, BMI, weight, height, or age.

View Article: PubMed Central - PubMed

Affiliation: Concept Clinic, Geneva, Switzerland.

ABSTRACT

Background: Extracorporeal shock wave therapy has been successfully introduced for the treatment of cellulite in recent years. However, it is still unknown whether the individual clinical outcome of cellulite treatment with extracorporeal shock wave therapy can be predicted by the patient's individual cellulite grade at baseline, individual patient age, body mass index (BMI), weight, and/or height.

Methods: Fourteen Caucasian females with cellulite were enrolled in a prospective, single-center, randomized, open-label Phase II study. The mean (± standard error of the mean) cellulite grade at baseline was 2.5±0.09 and mean BMI was 22.8±1.17. All patients were treated with radial extracorporeal shock waves using the Swiss DolorClast(®) device (Electro Medical Systems, S.A., Nyon, Switzerland). Patients were treated unilaterally with 2 weekly treatments for 4 weeks on a randomly selected side (left or right), totaling eight treatments on the selected side. Treatment was performed at 3.5-4.0 bar, with 15,000 impulses per session applied at 15 Hz. Impulses were homogeneously distributed over the posterior thigh and buttock area (resulting in 7,500 impulses per area). Treatment success was evaluated after the last treatment and 4 weeks later by clinical examination, photographic documentation, contact thermography, and patient satisfaction questionnaires.

Results: The mean cellulite grade improved from 2.5±0.09 at baseline to 1.57±0.18 after the last treatment (ie, mean δ-1 was 0.93 cellulite grades) and 1.68±0.16 at follow-up (ie, mean δ-2 was 0.82 cellulite grades). Compared with baseline, no patient's condition worsened, the treatment was well tolerated, and no unwanted side effects were observed. No statistically significant (ie, P<0.05) correlation was found between individual values for δ-1 and δ-2 and cellulite grade at baseline, BMI, weight, height, or age.

Conclusion: Radial shock wave therapy is a safe and effective treatment option for cellulite. The individual clinical outcome cannot be predicted by the patient's individual cellulite grade at baseline, BMI, weight, height, or age.

No MeSH data available.


Related in: MedlinePlus

Treatment of two patients (1, 2) with cellulite using radial extracorporeal shock wave therapy.Notes: (A1 and A2) Clinical picture at baseline. (B1 and B2) Contact thermography at baseline. (C1 and C2) Clinical picture 4 weeks after the last treatment (follow-up). (D1 and D2) Contact thermography at follow-up. (A1–D1) A 29-year-old female (body mass index 32.9, weight 84.3 kg, height 160 cm). Radial extracorporeal shock wave therapy performed on the left side improved the cellulite from grade 3 at baseline to grade 1–2 at follow-up (ie, δ-2 was 1.5). Despite this objectively substantial treatment success, the patient’s satisfaction was only 5 on a scale ranging from 0 (maximum dissatisfaction) to 10 (maximum satisfaction). (A2–D2) A 51-year-old female (body mass index 20.8; weight 53.3 kg; height 160 cm). Radial extracorporeal shock wave therapy performed on the right side improved the cellulite from grade 2–3 at baseline to grade 1–1.5 at follow-up (ie, δ-2 was 1.25). This patient was very satisfied with the treatment (9 on a scale ranging from 0 to 10). Patient consent was obtained to publish the above images.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4043818&req=5

f3-ccid-7-171: Treatment of two patients (1, 2) with cellulite using radial extracorporeal shock wave therapy.Notes: (A1 and A2) Clinical picture at baseline. (B1 and B2) Contact thermography at baseline. (C1 and C2) Clinical picture 4 weeks after the last treatment (follow-up). (D1 and D2) Contact thermography at follow-up. (A1–D1) A 29-year-old female (body mass index 32.9, weight 84.3 kg, height 160 cm). Radial extracorporeal shock wave therapy performed on the left side improved the cellulite from grade 3 at baseline to grade 1–2 at follow-up (ie, δ-2 was 1.5). Despite this objectively substantial treatment success, the patient’s satisfaction was only 5 on a scale ranging from 0 (maximum dissatisfaction) to 10 (maximum satisfaction). (A2–D2) A 51-year-old female (body mass index 20.8; weight 53.3 kg; height 160 cm). Radial extracorporeal shock wave therapy performed on the right side improved the cellulite from grade 2–3 at baseline to grade 1–1.5 at follow-up (ie, δ-2 was 1.25). This patient was very satisfied with the treatment (9 on a scale ranging from 0 to 10). Patient consent was obtained to publish the above images.

Mentions: The mean cellulite grade improved from 2.5±0.09 (range 2–3) at baseline to 1.57±0.18 (range 0.25–2.75) at the end of the treatment (ie, the mean δ-1 was 0.93 cellulite grades). At the end of the follow-up period, the mean cellulite grade was 1.68±0.16, ranging between 0.5 and 2.75 (ie, the mean δ-2 was 0.82 cellulite grades). The individual δ-1 varied between 0 grades (ie, no improvement) and 1.75 grades, and the individual δ-2 between 0 grades and 1.5 grades (Figure 3). Accordingly, compared with baseline, no patient’s skin condition worsened during treatment and follow-up. The treatment was well tolerated and no unwanted side effects were observed (note that discomfort during treatment and reddening of the skin up to 24 hours after each treatment session are usual side effects of RSWT and were therefore not considered unwanted side effects).


Predictability of the individual clinical outcome of extracorporeal shock wave therapy for cellulite.

Schlaudraff KU, Kiessling MC, Császár NB, Schmitz C - Clin Cosmet Investig Dermatol (2014)

Treatment of two patients (1, 2) with cellulite using radial extracorporeal shock wave therapy.Notes: (A1 and A2) Clinical picture at baseline. (B1 and B2) Contact thermography at baseline. (C1 and C2) Clinical picture 4 weeks after the last treatment (follow-up). (D1 and D2) Contact thermography at follow-up. (A1–D1) A 29-year-old female (body mass index 32.9, weight 84.3 kg, height 160 cm). Radial extracorporeal shock wave therapy performed on the left side improved the cellulite from grade 3 at baseline to grade 1–2 at follow-up (ie, δ-2 was 1.5). Despite this objectively substantial treatment success, the patient’s satisfaction was only 5 on a scale ranging from 0 (maximum dissatisfaction) to 10 (maximum satisfaction). (A2–D2) A 51-year-old female (body mass index 20.8; weight 53.3 kg; height 160 cm). Radial extracorporeal shock wave therapy performed on the right side improved the cellulite from grade 2–3 at baseline to grade 1–1.5 at follow-up (ie, δ-2 was 1.25). This patient was very satisfied with the treatment (9 on a scale ranging from 0 to 10). Patient consent was obtained to publish the above images.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4043818&req=5

f3-ccid-7-171: Treatment of two patients (1, 2) with cellulite using radial extracorporeal shock wave therapy.Notes: (A1 and A2) Clinical picture at baseline. (B1 and B2) Contact thermography at baseline. (C1 and C2) Clinical picture 4 weeks after the last treatment (follow-up). (D1 and D2) Contact thermography at follow-up. (A1–D1) A 29-year-old female (body mass index 32.9, weight 84.3 kg, height 160 cm). Radial extracorporeal shock wave therapy performed on the left side improved the cellulite from grade 3 at baseline to grade 1–2 at follow-up (ie, δ-2 was 1.5). Despite this objectively substantial treatment success, the patient’s satisfaction was only 5 on a scale ranging from 0 (maximum dissatisfaction) to 10 (maximum satisfaction). (A2–D2) A 51-year-old female (body mass index 20.8; weight 53.3 kg; height 160 cm). Radial extracorporeal shock wave therapy performed on the right side improved the cellulite from grade 2–3 at baseline to grade 1–1.5 at follow-up (ie, δ-2 was 1.25). This patient was very satisfied with the treatment (9 on a scale ranging from 0 to 10). Patient consent was obtained to publish the above images.
Mentions: The mean cellulite grade improved from 2.5±0.09 (range 2–3) at baseline to 1.57±0.18 (range 0.25–2.75) at the end of the treatment (ie, the mean δ-1 was 0.93 cellulite grades). At the end of the follow-up period, the mean cellulite grade was 1.68±0.16, ranging between 0.5 and 2.75 (ie, the mean δ-2 was 0.82 cellulite grades). The individual δ-1 varied between 0 grades (ie, no improvement) and 1.75 grades, and the individual δ-2 between 0 grades and 1.5 grades (Figure 3). Accordingly, compared with baseline, no patient’s skin condition worsened during treatment and follow-up. The treatment was well tolerated and no unwanted side effects were observed (note that discomfort during treatment and reddening of the skin up to 24 hours after each treatment session are usual side effects of RSWT and were therefore not considered unwanted side effects).

Bottom Line: Impulses were homogeneously distributed over the posterior thigh and buttock area (resulting in 7,500 impulses per area).No statistically significant (ie, P<0.05) correlation was found between individual values for δ-1 and δ-2 and cellulite grade at baseline, BMI, weight, height, or age.The individual clinical outcome cannot be predicted by the patient's individual cellulite grade at baseline, BMI, weight, height, or age.

View Article: PubMed Central - PubMed

Affiliation: Concept Clinic, Geneva, Switzerland.

ABSTRACT

Background: Extracorporeal shock wave therapy has been successfully introduced for the treatment of cellulite in recent years. However, it is still unknown whether the individual clinical outcome of cellulite treatment with extracorporeal shock wave therapy can be predicted by the patient's individual cellulite grade at baseline, individual patient age, body mass index (BMI), weight, and/or height.

Methods: Fourteen Caucasian females with cellulite were enrolled in a prospective, single-center, randomized, open-label Phase II study. The mean (± standard error of the mean) cellulite grade at baseline was 2.5±0.09 and mean BMI was 22.8±1.17. All patients were treated with radial extracorporeal shock waves using the Swiss DolorClast(®) device (Electro Medical Systems, S.A., Nyon, Switzerland). Patients were treated unilaterally with 2 weekly treatments for 4 weeks on a randomly selected side (left or right), totaling eight treatments on the selected side. Treatment was performed at 3.5-4.0 bar, with 15,000 impulses per session applied at 15 Hz. Impulses were homogeneously distributed over the posterior thigh and buttock area (resulting in 7,500 impulses per area). Treatment success was evaluated after the last treatment and 4 weeks later by clinical examination, photographic documentation, contact thermography, and patient satisfaction questionnaires.

Results: The mean cellulite grade improved from 2.5±0.09 at baseline to 1.57±0.18 after the last treatment (ie, mean δ-1 was 0.93 cellulite grades) and 1.68±0.16 at follow-up (ie, mean δ-2 was 0.82 cellulite grades). Compared with baseline, no patient's condition worsened, the treatment was well tolerated, and no unwanted side effects were observed. No statistically significant (ie, P<0.05) correlation was found between individual values for δ-1 and δ-2 and cellulite grade at baseline, BMI, weight, height, or age.

Conclusion: Radial shock wave therapy is a safe and effective treatment option for cellulite. The individual clinical outcome cannot be predicted by the patient's individual cellulite grade at baseline, BMI, weight, height, or age.

No MeSH data available.


Related in: MedlinePlus